Home>Topics>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International VRX

  1. All
  2. Commentary
  3. Headlines
    1. Valeant Pharmaceuticals sees third-quarter sales boost

      Headlines

      Mon, 29 Sep 2014

      Sept 29 (Reuters) - Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, on Monday said it expects sales to rise 15 percent in the third quarter but...

    2. CANADA STOCKS-TSX opens sharply lower; banks, Valeant lead retreat

      Headlines

      Mon, 29 Sep 2014

      main stock index opened sharply lower on Monday, with the heavily weighted financial stocks and Valeant Pharmaceuticals International leading the retreat. The Toronto Stock Exchange's S&P/TSX composite index was down 112

    3. Wall Street Breakfast: Billions Withdrawn From Pimco Following Gross's Departure

      Headlines

      Mon, 29 Sep 2014

      By Wall Street Breakfast : Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Long idea on WAG (Walgreen) by Alexander J. ...

    4. More concerns surface over Allergan's new bid

      Headlines

      Sun, 28 Sep 2014

      Another Allergan (NYSE: AGN ) investor has spoken out against the company's pursuit of a costly purchase to fend off Valeant's (NYSE: VRX ) $54B takeover bid. Jackson Square, the eighth largest investor in Allergan, now joins T. Rowe Price (NASDAQ: TROW ), announcing its dissatisfaction with the ...

    5. Can Valeant's Glaucoma Drug Peak Sales Be Much Lower Than Claimed?

      Headlines

      Fri, 26 Sep 2014

      By Uncommon Profit Investor : I was inspired to write this article by SA commenters who work in the eyecare field. They know a lot more than me of course. One said he has extensive ophthalmology experience and the other is an optometrist. Both of them strongly agree that Valeant's claim about ...

    6. ValueAct returns to Valeant board, plans to raise stake

      Headlines

      Thu, 25 Sep 2014

      (Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.

    7. UPDATE 2-ValueAct returns to Valeant board, plans to raise stake

      Headlines

      Thu, 25 Sep 2014

      Sept 25 (Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for...

    8. ValueAct returns to Valeant board, plans to raise stake

      Headlines

      Thu, 25 Sep 2014

      (Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.

    9. UPDATE 1-ValueAct returns to Valeant board, plans to raise stake

      Headlines

      Thu, 25 Sep 2014

      Sept 25 (Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for...

    10. CANADA STOCKS-TSX opens lower as gold-mining shares weigh

      Headlines

      Thu, 25 Sep 2014

      Thursday as a decline in the price of bullion sent gold-mining shares lower, offsetting a gain in Valeant Pharmaceuticals International Inc. The Toronto Stock Exchange's S&P/TSX composite index was down 78.66 points, or 0

    « Prev12345Next »
    Content Partners